HCID 86665172, compound → HCID 66871916, compound
Reaction equation
[CH3:1][Mg]Br.[CH3:4][O:5][C:6]1[CH:36]=[CH:35][C:9]([CH2:10][N:11]2[CH:15]=[C:14]([C:16]3[N:17]=[C:18]([O:21][C:22]4[CH:27]=[CH:26][CH:25]=[C:24]([CH3:28])[N:23]=4)[S:19][CH:20]=3)[C:13]([C:29](N(OC)C)=[O:30])=[N:12]2)=[CH:8][CH:7]=1>C1COCC1.CCOC(C)=O.Cl>[CH3:4][O:5][C:6]1[CH:7]=[CH:8][C:9]([CH2:10][N:11]2[CH:15]=[C:14]([C:16]3[N:17]=[C:18]([O:21][C:22]4[CH:27]=[CH:26][CH:25]=[C:24]([CH3:28])[N:23]=4)[S:19][CH:20]=3)[C:13]([C:29](=[O:30])[CH3:1])=[N:12]2)=[CH:35][CH:36]=1Participants
6
Procedure
According to Scheme 5, Step 5: Methylmagnesium bromide 3 M (148 μmol, 49 μL) was added dropwise at room temperature to a solution of 1-(4-methoxybenzyl)-N-methoxy-N-methyl-4-(2-(6-methylpyridin-2-yloxy)thiazol-4-yl)-1H-pyrazole-3-carboxamide (99 μmol, 46 mg) in THF (0.5 mL) and the reaction mixture was stirred for 1 hour at room temperature. The reaction was diluted with EtOAc and with an aqueous solution of HCl 1M. The aqueous phase was extracted with EtOAc. The organic phase was dried over Na2SO4, was filtered and was concentrated to yield 1-(1-(4-methoxybenzyl)-4-(2-(6-methylpyridin-2-yloxy)thiazol-4-yl)-1H-pyrazol-3-yl)ethanone (0.10 mmol, 42 mg, 100%) as a beige solid. The mixture was used without further purification.
Workup
- extractionThe aqueous phase was extracted with EtOAc
- dry with materialThe organic phase was dried over Na2SO4
- filtrationwas filtered
- concentrationwas concentrated
Sources & evidence
- ORD record
- ord-68b44f6f323b4078a7b8caf45b21df99
- Source dataset
- uspto-grants-2013_08
- Patent number
- US08513252B2
Reaction notes
Loading…